Raymond James Maintains Sector Perform on Tecnoglass, Raises Price Target to $42

Raymond James analyst Joshua Wilson maintains Tecnoglass (NYSE:TGLS) with a Sector Perform and raises the price target from $35 to $42.

byBenzinga Newsdesk

February 28, 2023

1 minute read

Raymond James analyst Joshua Wilson maintains Tecnoglass (NYSE:TGLS) with a Sector Perform and raises the price target from $35 to $42.

Jefferies Downgrades Athira Pharma to Hold, Lowers Price Target to $3

By Benzinga Newsdesk

Today, 3:47 AM

Jefferies analyst Andrew Tsai downgrades Athira Pharma (NASDAQ:ATHA) from Buy to Hold and lowers the price target from $32 to $3.

ATHA

Barclays Upgrades Illumina to Equal-Weight, Raises Price Target to $400

By Benzinga Newsdesk

Today, 3:47 AM

Barclays analyst Luke Sergott upgrades Illumina (NASDAQ:ILMN) from Underweight to Equal-Weight and raises the price target from $350 to $400.

ILMN

News

Blue Water Vaccines Reports Expanded License Deal With St. Jude Children’s Hospital For Novel Bacterial Vaccine Platform, No Terms Disclosed

By Benzinga Newsdesk

Today, 3:47 AM

Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or “the Company”), a biopharmaceutical company developing transformational vaccines, today announced an expanded license

BWV

StoneX Group Q3 EPS $1.67, Inline, Sales $431.50M Beat $280.14M Estimate

By Benzinga Newsdesk

Today, 3:47 AM

StoneX Group (NASDAQ:SNEX) reported quarterly earnings of $1.67 per share which met the analyst consensus estimate. This is a 10.7 percent decrease over earnings of $1.87 per share from the same period last year. The

SNEX

Raymond James Maintains Sector Perform on Tecnoglass, Raises Price Target to $42

Related Posts

Jefferies Downgrades Athira Pharma to Hold, Lowers Price Target to $3

Barclays Upgrades Illumina to Equal-Weight, Raises Price Target to $400

Blue Water Vaccines Reports Expanded License Deal With St. Jude Children’s Hospital For Novel Bacterial Vaccine Platform, No Terms Disclosed

StoneX Group Q3 EPS $1.67, Inline, Sales $431.50M Beat $280.14M Estimate